VT
CLPT icon

Vise Technologies’s ClearPoint Neuro CLPT Stock Holding History

Vise Technologies’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,950
Closed -$92.7K – 338
2022
Q4 		$92.7K Sell
10,950
-3,600
-25% -$34.1K 0.03% 323
2022
Q3 		$151K Buy
+14,550
New +$192K 0.06% 285

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return

Vise Technologies's CLPT Position: Q1 2023 in Review

Vise Technologies sold out of ClearPoint Neuro (CLPT) in Q1 2023, closing a stake of 10,950 shares — an estimated $92.7K sold.

Vise Technologies first reported a position in CLPT in Q3 2022 and held it in 2 quarters. The position peaked at $151K in Q3 2022. 59 funds tracked by Wall St. Rank hold CLPT as of Q1 2023.

  • Vise Technologies reported no remaining ClearPoint Neuro position as of Q1 2023 after selling out during the quarter.
  • Vise Technologies sold 10,950 ClearPoint Neuro shares in Q1 2023, an estimated $92.7K.
  • Vise Technologies first reported a position in ClearPoint Neuro in Q3 2022 and held it in 2 quarters.
  • Vise Technologies's ClearPoint Neuro position peaked at $151K in Q3 2022.
  • 59 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2023.

Based on Vise Technologies's 13F filing for Q1 2023, filed 10 May 2023.